Cytek Biosciences Stock Market Value
| CTKB Stock | USD 6.53 0.03 0.46% |
| Symbol | Cytek |
Cytek Biosciences Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytek Biosciences. If investors know Cytek will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytek Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.658 | Earnings Share (0.08) | Revenue Per Share 1.527 | Quarterly Revenue Growth 0.073 | Return On Assets (0.03) |
The market value of Cytek Biosciences is measured differently than its book value, which is the value of Cytek that is recorded on the company's balance sheet. Investors also form their own opinion of Cytek Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Cytek Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytek Biosciences' market value can be influenced by many factors that don't directly affect Cytek Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytek Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytek Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytek Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cytek Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cytek Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cytek Biosciences.
| 06/08/2023 |
| 11/29/2024 |
If you would invest 0.00 in Cytek Biosciences on June 8, 2023 and sell it all today you would earn a total of 0.00 from holding Cytek Biosciences or generate 0.0% return on investment in Cytek Biosciences over 540 days. Cytek Biosciences is related to or competes with Orthopediatrics Corp, Electromed, Pulmonx Corp, Treace Medical, Orthofix Medical, Neuropace, and Inogen. Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific adv... More
Cytek Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cytek Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cytek Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.23 | |||
| Information Ratio | 0.0422 | |||
| Maximum Drawdown | 43.35 | |||
| Value At Risk | (5.31) | |||
| Potential Upside | 4.62 |
Cytek Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cytek Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cytek Biosciences' standard deviation. In reality, there are many statistical measures that can use Cytek Biosciences historical prices to predict the future Cytek Biosciences' volatility.| Risk Adjusted Performance | 0.058 | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.50) | |||
| Sortino Ratio | 0.0564 | |||
| Treynor Ratio | 0.0748 |
Cytek Biosciences Backtested Returns
Cytek Biosciences appears to be moderately volatile, given 3 months investment horizon. Cytek Biosciences secures Sharpe Ratio (or Efficiency) of 0.0778, which signifies that the company had a 0.0778% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Cytek Biosciences, which you can use to evaluate the volatility of the firm. Please makes use of Cytek Biosciences' Risk Adjusted Performance of 0.058, mean deviation of 3.2, and Downside Deviation of 4.23 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Cytek Biosciences holds a performance score of 6. The firm shows a Beta (market volatility) of 4.73, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cytek Biosciences will likely underperform. Please check Cytek Biosciences' expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Cytek Biosciences' price patterns will revert.
Auto-correlation | 0.01 |
Virtually no predictability
Cytek Biosciences has virtually no predictability. Overlapping area represents the amount of predictability between Cytek Biosciences time series from 8th of June 2023 to 4th of March 2024 and 4th of March 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cytek Biosciences price movement. The serial correlation of 0.01 indicates that just 1.0% of current Cytek Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.01 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.45 |
Cytek Biosciences lagged returns against current returns
Autocorrelation, which is Cytek Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cytek Biosciences' stock expected returns. We can calculate the autocorrelation of Cytek Biosciences returns to help us make a trade decision. For example, suppose you find that Cytek Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cytek Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cytek Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cytek Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cytek Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Cytek Biosciences Lagged Returns
When evaluating Cytek Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cytek Biosciences stock have on its future price. Cytek Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cytek Biosciences autocorrelation shows the relationship between Cytek Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Cytek Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cytek Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytek Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytek Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytek Biosciences Stock:Check out Cytek Biosciences Correlation, Cytek Biosciences Volatility and Cytek Biosciences Alpha and Beta module to complement your research on Cytek Biosciences. For information on how to trade Cytek Stock refer to our How to Trade Cytek Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Cytek Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.